Rabies exposure is a medical emergency requiring immediate wound care and post-exposure prophylaxis (PEP), as rabies is nearly 100% fatal once clinical symptoms develop but is entirely preventable with timely PEP. [1-2] Approximately 30,000–60,000 patients initiate PEP annually in the US, most commonly through the ED. [3]
1. History
- Type of exposure: Bite vs. non-bite (scratch, mucous membrane contact, open wound contamination with saliva/neural tissue) [4]
- Animal species: Dog, cat, bat, raccoon, skunk, fox, coyote, or other wild mammal — bats are the most common source in the US; dogs predominate worldwide [4-5]
- Provoked vs. unprovoked: Unprovoked attacks are more likely to involve rabid animals [4]
- Anatomic site of bite: Face, head, neck, and hands carry highest risk due to dense innervation and proximity to CNS [1][6]
- Time since exposure: Incubation typically weeks to months; PEP should begin immediately but can be initiated even months after exposure [1][4]
- Animal status: Is the animal available for observation or testing? Domestic animals (dogs, cats, ferrets) can be observed for 10 days [1]
- Geographic location: Rabies endemicity varies by region; consult local/state health department [4][7]
- Prior rabies vaccination history: Determines PEP regimen (2-dose vs. 4-dose, with or without HRIG) [8-9]
2. Alarm Features
- Any neurologic symptoms after animal exposure: paresthesia/pain at bite site, anxiety, agitation, hydrophobia, aerophobia, dysphagia, hypersalivation, autonomic dysfunction [1][10]
- Bat found in room with sleeping person, unattended child, mentally disabled, or intoxicated person — even without visible bite [4]
- Unprovoked attack by a wild terrestrial carnivore (skunk, raccoon, fox, coyote) [4]
- Animal exhibiting abnormal behavior: hypersalivation, paralysis, unprovoked aggression, abnormal vocalization [1]
- Bites to face, head, neck, or hands — shorter incubation period and higher transmission risk [1][6]
- Delay in PEP initiation — every PEP failure documented in the US involved deviation from protocol (wounds not cleansed, no HRIG given, or vaccine injected in gluteal area) [11-12]
3. Medications
- Human Rabies Immune Globulin (HRIG): 20 IU/kg, infiltrated into and around wound(s); remainder given IM at site distant from vaccine. Given once on Day 0 (can be given up to Day 7 if initially missed) [4][13-14]
- Rabies vaccine (HDCV — Imovax Rabies, or PCECV — RabAvert): 1 mL IM per dose [4][9]
- Unvaccinated, immunocompetent: 4 doses on Days 0, 3, 7, and 14 (ACIP 2010 reduced schedule) + HRIG [8]
- Immunocompromised: 5 doses on Days 0, 3, 7, 14, and 28 + HRIG [8-9]
- Previously vaccinated: 2 doses on Days 0 and 3 only; no HRIG (may blunt anamnestic response) [4][9]
- Tetanus prophylaxis: Update as indicated for wound management [4]
- Antibiotics: Consider for contaminated or deep bite wounds to prevent secondary bacterial infection [4]
- Contraindications: None for PEP — rabies is uniformly fatal, so there are no contraindications to PEP after a true exposure [4]
- Caution: Chloroquine and immunosuppressive agents may reduce vaccine immunogenicity; post-vaccination serology should be checked [9][15]
- Do NOT inject vaccine in the gluteal area — associated with lower antibody titers and documented PEP failures [4][11]
4. Diet
- No specific dietary triggers or restrictions related to rabies exposure
- Ensure adequate hydration and nutrition, particularly if wound care is extensive or patient is anxious/distressed
5. Review of Systems
- Neurologic: Paresthesia, pain, or pruritus at bite site; headache; anxiety; confusion; agitation; difficulty swallowing; fear of water/air [1][10][16]
- Constitutional: Fever, malaise, fatigue [1][17]
- Autonomic: Diaphoresis, piloerection, cardiac arrhythmias, hypersalivation [1][10]
- GI: Nausea, vomiting [1]
- Musculoskeletal: Weakness, paralysis (especially in paralytic form) [10][18]
- Psychiatric: Anxiety, agitation, delirium — may be the presenting complaint [1]
6. Collateral History and Family History
- Witnesses to the exposure event: Confirm bite vs. scratch vs. no contact; identify the animal
- Animal vaccination status: A currently vaccinated domestic dog, cat, or ferret is unlikely to be rabid [4]
- Animal owner information: Facilitate 10-day observation period for dogs, cats, and ferrets [1]
- Travel history: Recent travel to rabies-endemic regions (Asia, Africa, Latin America) [19]
- Occupational history: Veterinarians, animal control officers, laboratory workers, spelunkers [4]
- Family history is generally not relevant to rabies exposure management
7. Risk Factors
- High-risk animal species: Bats (US #1 source), skunks, raccoons, foxes, coyotes [4][7]
- Geographic endemicity: Dogs remain the primary reservoir in most of Asia and Africa [16][19]
- Unprovoked attack [4]
- Deep or multiple bites, especially to highly innervated areas (face, hands) [1][6]
- Lack of pre-exposure prophylaxis in high-risk occupations or travelers [15][19]
- Immunocompromised status: May have inadequate response to vaccination [8-9]
- Low-risk exposures: Small rodents (squirrels, hamsters, rats, mice) and lagomorphs (rabbits, hares) are almost never infected and have not transmitted rabies to humans in the US [4]
8. Differential Diagnosis
When evaluating the wound itself, the differential is straightforward (animal bite management). When a patient presents with neurologic symptoms after a remote exposure:
- Other viral encephalitides: Herpes simplex, arboviruses (West Nile, Eastern equine), Nipah virus [5]
- Guillain-Barré syndrome: Paralytic rabies closely mimics GBS, but rabies features bladder incontinence, myoedema, and progression to coma [10]
- Tetanus: Trismus and muscle rigidity; can overlap with rabies presentation [10]
- Transverse myelitis / neuromyelitis optica: Reported as atypical rabies presentation [10]
- Psychiatric illness: Agitation and anxiety may be misattributed; always consider rabies with compatible exposure history [1]
- Drug/toxin-mediated encephalopathy
- Bacterial meningitis/encephalitis
9. Past Medical History
- Prior rabies vaccination: Determines PEP regimen — previously vaccinated patients need only 2 doses of vaccine and no HRIG [4][8]
- Immunocompromising conditions: HIV/AIDS, organ transplant, chemotherapy, chronic corticosteroid use — require 5-dose vaccine series and post-vaccination serology [8-9]
- Tetanus vaccination status: Update Tdap/Td as indicated
- Allergies: Document any prior reactions to rabies vaccine components (e.g., polygeline, antibiotics used in manufacturing) [20]
- History of organ/tissue transplantation: Rare cases of rabies transmitted via corneal and solid organ transplants [4]
10. Physical Exam
- Wound assessment: Location, depth, number of wounds; evidence of penetration through skin by teeth [4]
- Vital signs: Fever, tachycardia, hypertension (autonomic instability if symptomatic) [10]
- Neurologic exam: Mental status, cranial nerves, motor strength, sensation (especially at bite site), reflexes, signs of ascending paralysis [10][18]
- Look for occult wounds: Bat bites can be extremely small and easily missed — examine carefully [4]
- Lymphadenopathy: Regional lymph nodes draining the bite site
- Signs of secondary infection: Erythema, warmth, purulent drainage, cellulitis, lymphangitis
11. Lab Studies
For the exposure (pre-symptomatic) patient, routine labs are generally not indicated. Labs become critical if clinical rabies is suspected:
- Routine labs: CBC, BMP, LFTs — nonspecific but useful for baseline
- CSF analysis: Mild lymphocytic pleocytosis may be seen; rabies antibody in CSF confirms diagnosis in unvaccinated patients [1][21]
- Rabies-specific testing (consult public health/CDC): [21]
- NAAT (RT-PCR) on saliva (sensitivity ~70% on single sample; >98% on serial samples) [10][16]
- Immunohistochemistry on nuchal skin biopsy (nape of neck) — nearly 100% sensitive [10]
- Serum and CSF rabies virus neutralizing antibody (RFFIT) [22-23]
- Post-vaccination serology: Indicated for immunocompromised patients or significant deviations from PEP schedule [15][21]
- Animal testing: If the animal is captured/killed, brain tissue should be sent for direct fluorescent antibody (DFA) testing [5]
12. Imaging
- Not routinely indicated for rabies exposure management
- Brain MRI (if clinical rabies suspected): Subtle T2/FLAIR signal changes in brainstem, hippocampus, hypothalamus, and deep gray matter; typically no gadolinium enhancement (unlike other encephalitides) [10]
- CT head: Usually normal; may be obtained to rule out other causes of encephalopathy
- Wound imaging: X-ray or CT if concern for retained foreign body (tooth fragment), fracture, or deep tissue involvement
13. Special Tests
- Direct fluorescent antibody (DFA) test: Gold standard for animal brain tissue testing — results available within hours [5]
- Rabies risk assessment tools: CDC/state health department consultation; Wisconsin Rabies Algorithm for common exposure scenarios [7]
- Post-vaccination titer check (RFFIT): Indicated for immunocompromised patients; adequate response defined as ≥0.5 IU/mL [9][15]
- Nuchal skin biopsy: 4 mm punch biopsy from nape of neck containing hair follicles — for immunohistochemistry and RT-PCR in suspected clinical cases [10][21]
14. ECG
- Not routinely indicated for rabies exposure
- If clinical rabies develops, cardiac monitoring is essential — autonomic dysfunction can cause arrhythmias, and cardiac arrest is a common cause of death [1][10]
- At least one case was initially misdiagnosed as a cardiac condition due to autonomic dysfunction mimicking primary cardiac disease [1]
15. Assessment
Exposure categorization (WHO classification): [16][24]
- Category I: Touching/feeding animal, licks on intact skin → no PEP needed
- Category II: Nibbling of uncovered skin, minor scratches without bleeding → vaccine only
- Category III: Single or multiple transdermal bites/scratches, licks on broken skin, mucous membrane contamination, bat exposures → vaccine + HRIG
Key clinical pearls
- Rabies is almost 100% fatal once symptoms appear — there is no effective treatment for clinical rabies [2][18]
- PEP is virtually 100% effective when administered correctly [11-12]
- Every documented PEP failure involved protocol deviations [11-12]
- Incubation period is typically 1–3 months but ranges from days to years [1][17]
- In the US, rabies diagnosis is almost always missed at the first clinical encounter [1]
16. Treatment Plan
Immediate wound care: [4][6][16]
- Copious irrigation with soap and water for at least 15 minutes — reduces rabies risk by up to 50% in animal studies
- Apply virucidal agent (povidone-iodine or alcohol-based antiseptic)
- Avoid primary wound closure when possible to prevent deeper contamination
- Tetanus prophylaxis as indicated
- Antibiotics for contaminated/deep wounds (amoxicillin-clavulanate is first-line for mammalian bites)
PEP for previously unvaccinated, immunocompetent patients: [8][14]
- HRIG 20 IU/kg: Infiltrate full dose into and around wound(s); inject remainder IM at site distant from vaccine. Given once on Day 0 (up to Day 7 if delayed)
- Rabies vaccine 1 mL IM (deltoid in adults; anterolateral thigh in children): Days 0, 3, 7, and 14
- HRIG and vaccine must never be given at the same anatomic site or in the same syringe [4][14]
PEP for previously vaccinated patients: [4][9]
- Vaccine only: 1 mL IM on Days 0 and 3
- No HRIG — may blunt anamnestic immune response
PEP for immunocompromised patients: [8-9]
- 5-dose vaccine series: Days 0, 3, 7, 14, and 28 + HRIG
- Post-vaccination serology recommended
17. Disposition
- Most patients are discharged from the ED after wound care, first vaccine dose, and HRIG administration [3][25]
- Admission criteria: Signs of clinical rabies (encephalitis, hydrophobia, paralysis); severe/extensive wounds requiring surgical management; hemodynamic instability
- Observation: Consider for extensive facial wounds, significant anxiety, or complex wound management
- Specialist consultation triggers:
- Infectious disease / public health: Uncertainty about PEP indication; consult state/local health department or CDC [7][21][25]
- Surgery/plastics: Complex facial or hand wounds
- Neurology/critical care: If clinical rabies is suspected
- Ensure follow-up plan for remaining vaccine doses before discharge [25]
18. Follow Up / Return Precautions
- Vaccine schedule adherence is critical: Remaining doses on Days 3, 7, and 14 (or Day 28 for immunocompromised) — can be given at PCP office, urgent care, or ED [8-9]
- Animal observation: If a domestic dog, cat, or ferret is available, observe for 10 days; PEP can be discontinued if the animal remains healthy [1][16]
- Return immediately for: Fever, paresthesia or pain at bite site, difficulty swallowing, anxiety/agitation, hydrophobia, muscle weakness, confusion [1][10]
- Wound care follow-up: 48–72 hours for wound check; signs of infection (increasing redness, swelling, purulent drainage, fever)
- Minor delays of a few days in the vaccine schedule are clinically inconsequential; longer lapses should prompt consultation with public health authorities [15]
- Patient counseling: Rabies is preventable with proper PEP; emphasize importance of completing the full vaccine series; reassure that PEP is virtually 100% effective when given correctly [11]
References
1. Rabies. — Ryan M. Wallace and David R. Shlim CDC Yellow Book. 2025.
2. Neuroimmunology of rabies: New insights into an ancient disease. — Bastos V, Pacheco V, Rodrigues ÉDL, et al. Journal of Medical Virology. 2023.
3. Implementation of Clinical Decision Support on Emergency Department Delivery of Human Rabies Immune Globulin. — Yuan F, Iso T, Rizk E, et al. JAMA Network Open. 2022.
4. FDA Drug Label. — Food and Drug Administration (DailyMed)..
5. Histopathology of vaccine‐preventable diseases. — Solomon IH, Milner DA. Histopathology. 2017.
6. Rabies and Other Lyssavirus Diseases. — Warrell MJ, Warrell DA. Lancet. 2004.
7. Risk of Rabies and Implications for Postexposure Prophylaxis Administration in the US. — Charniga K, Nakazawa Y, Brown J, Jeon S, Wallace RM. JAMA Network Open. 2023.
8. Use of a Reduced (4-Dose) Vaccine Schedule for Postexposure Prophylaxis to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices. — Rupprecht CE, Briggs D, Brown CM, et al. MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports. 2010.
9. FDA Drug Label. — Food and Drug Administration (DailyMed)..
10. Human Rabies: Neuropathogenesis, Diagnosis, and Management. — Hemachudha T, Ugolini G, Wacharapluesadee S, et al. The Lancet. Neurology. 2013.
11. Rabies. — Fishbein DB, Robinson LE. The New England Journal of Medicine. 1993.
12. Human Rabies Despite Post-Exposure Prophylaxis: A Systematic Review of Fatal Breakthrough Infections After Zoonotic Exposures. — Whitehouse ER, Mandra A, Bonwitt J, et al. The Lancet. Infectious Diseases. 2023.
13. Use of a Reduced (4-Dose) Vaccine Schedule for Postexposure Prophylaxis to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices. — Charles E. Rupprecht, Deborah Briggs, Catherine M. Brown, et al Advisory Committee on Immunization Practices (2010). 2010.
14. Use of a Reduced (4-Dose) Vaccine Schedule for Postexposure Prophylaxis to Prevent Human Rabies-Recommendations of the Advisory Committee on Immunization Practice. — Annals of Emergency Medicine. 2010.
15. Use of a Modified Preexposure Prophylaxis Vaccination Schedule to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. — Rao AK, Briggs D, Moore SM, et al. MMWR. Morbidity and Mortality Weekly Report. 2022.
16. Current Status of Rabies and Prospects for Elimination. — Fooks AR, Banyard AC, Horton DL, et al. Lancet. 2014.
17. Comparative Pathogenesis of Rabies in Bats and Carnivores, and Implications for Spillover to Humans. — Begeman L, GeurtsvanKessel C, Finke S, et al. The Lancet. Infectious Diseases. 2018.
18. Rabies: A Medical Perspective. — Jackson AC. Revue Scientifique Et Technique. 2018.
19. Boostability After Single-Visit Pre-Exposure Prophylaxis With Rabies Vaccine: A Randomised Controlled Non-Inferiority Trial. — Overduin LA, Koopman JPR, Prins C, et al. The Lancet. Infectious Diseases. 2024.
20. Prophylaxis against Rabies. — Rupprecht CE, Gibbons RV. The New England Journal of Medicine. 2004.
21. Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). — Miller JM, Binnicker MJ, Campbell S, et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2024.
22. An ELISA-based Method for Detection of Rabies Virus Nucleoprotein-Specific Antibodies in Human Antemortem Samples. — Realegeno S, Niezgoda M, Yager PA, et al. PloS One. 2018.
23. Utility of Rabies Neutralizing Antibody Detection in Cerebrospinal Fluid and Serum for Ante-Mortem Diagnosis of Human Rabies. — Damodar T, Mani RS, Prathyusha PV. PLoS Neglected Tropical Diseases. 2019.
24. Post-Exposure Prophylaxis Regimen of Rabies Monoclonal Antibody and Vaccine in Category 3 Potential Exposure Patients: A Phase 4, Open-Label, Randomised, Active-Controlled Trial. — Kulkarni PS, Potey AV, Kapse D, et al. Lancet. 2025.
25. Rabies Postexposure Prophylaxis: What the U.S. Emergency Medicine Provider Needs to Know. — Gibbons K, Dvoracek K. Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine. 2023.